High-performance computing to treat disease at individual level
Tailoring patient treatment so it is as individualised as the disease is at the heart of personalised medicine, which combines clinical and omics information. But there is still a long way to go before personalised medicine really thrives. For instance, current simulation software is insufficient to tackle medical problems like tumour evolution or patient-specific treatments. The EU-funded PerMedCoE project will provide an efficient and sustainable entry point to the new European High-Performance Computing (HPC) and exascale computing systems, in order to translate omics analyses into actionable models. The project’s main aim is to optimise four applications for cell-level simulations. It will also offer access to HPC/exascale-adapted and optimised software in order to integrate PerMed into the new European HPC/exascale ecosystem.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeRIA - Research and Innovation action